Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Is sun protection important during treatment
Semaglutide is already FDA-approved to treat obesity in adults after Novos Phase III trial showed an average 15% decrease in body weight for those taking semaglutide
Areas that once held volume may now appear deflated or aged
The company offers a digital program that combines medication, including GLP-1 drugs, with behavior change delivered through a proprietary intensive lifestyle intervention to treat the underlying biology that contributes to obesity, according to Calibrate Chief Medical Officer Kim Boyd, M.D
Treatment targets and drug choices should be individualised according to patient needs, aligned with NICE guidance and local formularies
US$ 28.32
US$ 21.03
US$ 21.42
US$ 21.89
